You are invited to participate in a research study at Weill Cornell Medicine/ New York Presbyterian Hospital (NYC). The purpose of this study is to better understand the effects of aortic graft surgery on the heart and the aorta in patients with Marfan syndrome and other genetic aortic conditions. Aortic graft surgery provides life-saving benefits for patients with aortic aneurysms, but long-term clinical events can still occur – especially in people with genetic conditions like Marfan syndrome. This study will use promising new cardiac MRI methods to look at the effects of aortic grafts on the heart. If your doctor did not order a cardiac MRI, our study sponsor (NIH) will cover the cost of the MRI for the research study. MRI results will be made available to study participants and their doctors. The ultimate goal of this study is to improve monitoring, treatments, and clinical outcomes for patients with Marfan syndrome and other genetic conditions. Your participation in this study is completely voluntary but will help us to achieve this important goal.

You may be eligible if you:

• Are over 18 years old.
• Have an aortic aneurysm and are being considered for aortic graft surgery.

You are not eligible if you:

• Cannot have an MRI because you have a pacemaker, defibrillator, or any other contraindication.
• Are very claustrophobic (have a fear of small spaces).
• Are pregnant.

What is involved?
You are being asked to undergo 2-3 cardiac MRI exams. The first MRI will be performed approximately 1 month before your surgery. Follow up MRIs will be performed after your surgery (about three months and one year). MRIs will ideally be performed with contrast (gadolinium). However, a non-contrast MRI can be performed if you prefer. During your study visit, you will be given a survey to complete. This survey will include an assessment of potential symptoms and your quality of life. Additionally, you will be given the option to donate a blood sample and aortic tissue (removed at time of surgery). Please note that blood and tissue donation are not at all mandatory to participate in the study. Participation in this study should not affect your surgery and clinical care. Each study visit will take ~60-90 minutes. MRI exams will take place at Weill Cornell Medicine/ New York Presbyterian Hospital (NYC). Our research team will work together with you to schedule your study visits on days/times convenient for you. Study participants will receive a $50 debit card to cover travel expenses for each study visit.

If you have any questions, or if you are interested in participating, please contact Dr. Jonathan Weinsaft at jww2001@med.cornell.edu or 212-746-2627.

Texas Children’s Hospital and Stanford are recruiting people with Marfan syndrome aged 10-25 years old for a study to evaluate the effects of moderate exercise.

Participants will attend two in-person study visits, each day lasting 5-7 hours, for comprehensive testing and exercise training. During each visit, the participant will undergo (at no cost):

• Cardiac MRI
• Exercise stress test
• Tonometry (non-invasive test of aortic stiffness)
• EndoPAT (non-invasive test of endothelial function)
• Ambulatory blood pressure monitoring
• Strength testing
• Quality of life surveys

For more information about this research study, please contact Okarys Bonilla at 832-826-5916 or oxbonill@texaschildrens.org

Researchers in the University of Pennsylvania Department of Ophthalmology are launching a study to investigate how Marfan Syndrome, Ehlers-Danlos Syndrome, and other inherited connective tissue diseases affect the eyes. The investigators believe that little is known about how these diseases present in the eyes, and hope that this study will provide more information and inspire future studies to develop targeted therapies.

The brief, 5-minute, anonymous survey asks for basic demographic information, genetic diagnosis, eye-related symptoms, and other health conditions. There is also an option to upload previously taken retinal imaging (e.g. fundus photography, optical coherence tomography). If you do not have your imaging with you currently, you will get a survey return code that you can use to upload images later.

The survey can be accessed at: https://redcap.med.upenn.edu/surveys/?s=DCR3RNJ4F9743FYD.

The genetic counseling program at the University of South Carolina is interested in learning about factors that impact an individual’s decision to pursue genetic testing and their experiences with obtaining insurance. Participation is limited to individuals with a personal or family history of aortopathy (i.e., enlarged/dilated/weak aorta, aortic aneurysm, aortic dissection) or cardiomyopathy (i.e., heart shape or function abnormalities, such as dilated, hypertrophic, etc.) and involves completion of a 15-20 minute survey. Study participants have the option to enter a raffle to receive one of ten available $10 VISA gift cards.

Who is eligible?

Individuals who wish to complete the study survey must meet each of the following criteria:

• Must be 18 years or older
• Must be a resident of the United States
• Must have either a clinical diagnosis or positive genetic test results for either aortopathy (enlarged/dilated/weak aorta, aortic aneurysm, aortic dissection ) and/or cardiomyopathy (dilated, hypertrophic, etc.) OR have a family member with a clinical diagnosis or positive genetic test results for either aortopathy (enlarged/dilated/weak aorta, aortic aneurysm, aortic dissection ) and/or cardiomyopathy (dilated, hypertrophic, etc.)
• Must have been offered or considered genetic testing for aortopathy and/or cardiomyopathy

Where can the survey be found?

Interested individuals can complete the survey here: https://redcap.link/2mkr7oe3

For more information or any questions regarding the study, please contact julia.schoeni@uscmed.sc.edu.

Are you interested in helping researchers develop the world’s largest database for children and young adults with genetic aortic disease? Researchers at Texas Children’s Hospital are interested in learning more about young people with aortic disease that has a genetic basis. They are asking for your help because there are currently no medical guidelines on how to best manage aortic dilation in children, and little is known about the long-term outcomes of these genetic conditions.

In an effort to learn more, researchers will collect clinical information from your medical records to better understand how the aorta changes over time, and how your genotype (your unique genetic code) affects your disease. This information will help create guidelines that will provide better tools for doctors to diagnose, estimate risks, and treat children and young adults with genetic aortic disease. These guidelines aim to improve the care and quality of life for individuals diagnosed with these conditions.

One is eligible to participate in the CLARITY study if they were diagnosed under age 50 and meet one of the following criteria:

1. 1. Classic Marfan syndrome with either FBN1 mutation or history of lens dislocation/subluxation
   2. Early-onset/ Neonatal/ Infantile Marfan syndrome with FBN1
      mutation
   3. Loeys-Dietz syndrome with TGFBR1, TGFBR2, TGFB2, TGFB3, SMAD2, or SMAD3 mutation
   4. Vascular Ehlers-Danlos syndrome with COL3A1 mutation
   5. Arterial Tortuosity syndrome with SLC2A10 mutation
   6. Shprintzen-Goldberg syndrome with SKI mutation
   7. Cutis Laxa Type 2B with recessive EFEMP2/FBLN4 mutations
   8. ACTA2-associated aortic or arterial disease
   9. FLNA-associated aortic or arterial disease
   10. LOX-associated aortic or arterial disease
   11. MYLK-associated aortic disease
   12. MYH11-associated aortic disease

To participate, you will be asked to sign a consent form and a medical records release form to allow the research team to collect personal medical information related to your genetic diagnosis. This information will be stored in a secure database and used for study analysis. Other than signing these forms, research participants will not be asked to take any further actions, such as attending research visits, participating in clinical trials, etc.

For more information, please visit the study website: clarityregistry.com

If you have any questions, or if you are interested in enrolling, please contact the study research coordinator, Nadia Espahbodi at nxespahb@texaschildrens.org.

Researchers at Penn State College of Medicine are interested in better understanding the economic impact of having Ehlers-Danlos syndromes (EDS) or hypermobility spectrum disorder (HSD).

Individuals who have EDS or HSD — or who have a family member with EDS or HSD — are invited to complete an anonymous online survey questionnaire. The aggregate results will be published in a peer-reviewed medical journal and made available to guide health services organization and policy.

Individuals must be 18 years of age or older and live in the United States to participate.

The survey questionnaire asks about approximate expenses for one calendar year: 2022. It will be helpful to gather financial expenses before beginning (such as medical bills, itemized tax return).

The estimated time to complete this questionnaire is 30 minutes. At any time, participants can save their responses and complete the questionnaire at a later time.

If one decides to fill out the survey, answering each question is completely voluntary. One may choose to stop at any time and may choose to skip questions they are not comfortable answering. This survey is voluntary and completely anonymous. Patients may withdraw before submitting the survey at any time. Patients who submit the survey voluntarily agree and give consent to participation in this research study.

Questions may be forwarded to the principal investigator of this study, Dr. Jane Schubart at: jschubart@pennstatehealth.psu.edu.

Link to the survey:  https://redcap.ctsi.psu.edu/surveys/?s=8DNJEWFWP44R7XJL

This announcement is regarding voluntary and anonymous participation in a research study at Michigan State University College of Osteopathic Medicine (MSUCOM) regarding the impact of skin manifestations of Marfan syndrome on patients of different genders, ethnicities, and skin color.

The purpose of the study is to understand how skin findings associated with Marfan syndrome, such as stretch marks, may affect the psychological, emotional, and social well beings of patients who have them.

The link to the online Qualtrics survey is below and takes approximately 3-5 minutes to complete.

If one decides to fill out the survey, answering each question is completely voluntary. One may choose to stop at any time and may choose to skip questions they are not comfortable answering. Again, this survey is voluntary and completely anonymous, and no personnel from MSUCOM will have access to any patient medical records or tissue samples. Patients may withdraw before submitting the survey at any time. Patients who submit the survey voluntarily agree and give consent to participation in this research study.

Patients must be 18 years of age or older to participate.

Questions may be forwarded to the principal investigator of this study, Dr. Raquel Ritchie, at rritchie@msu.edu.

Survey link: https://msu.co1.qualtrics.com/jfe/form/SV_3QOrZ5Xc8uAvsBU

The NIGMS (National Institute of General Medical Sciences) Repository, housed at the Coriell Institute, is a research biobank that collects blood and/or tissue samples from individuals with genetic diseases and makes them into cell lines and DNA for scientists to use in biomedical research. Loeys-Dietz syndrome (LDS), Vascular Ehlers-Danlos syndrome (VEDS), and Marfan syndrome were recently listed on the American College of Medical Genetics and Genomics list of actionable conditions for increased research.

Coriell is now accepting blood (for lymphoblasts) and skin biopsy (for fibroblasts) samples from individuals with LDS, VEDS, and Marfan syndrome as well as their family members and relatives from domestic and international locations around the world.

Donors will receive a sample collection kit, instructions, and all necessary materials for collecting samples and returning the kit free of charge. Sample donors are required to submit supporting clinical data (e.g., genetic test results, medical records, physician summary records) that describes the diagnosis.

To submit a sample to the NIGMS Repository, email NIGMS@coriell.org with the following information:

• The requested number of blood and skin biopsy collection kits for your family member(s)
• Full name and age (for children) of each family member who will donate samples
• The name, address, and phone number of the person or clinician to whom the collection kit(s) should be shipped.

Coriell does not conduct its own research but provides the materials for scientists around the world to perform research on genetic disorders. Also, Coriell does not provide donors with any results regarding their genetic disease nor information on their sample itself. For more information about Coriell and the sample donation process click here.

Who is eligible?

Individuals with Marfan syndrome confirmed by genetic testing (FBN1 gene mutation) who have:

• A diagnosis of “early-onset” or neonatal Marfan syndrome confirmed by a genetics or cardiology healthcare provider OR
• Cardiac valve disease or severe problems with heart valves before age 1.

What does the study involve?

• Review of your child’s medical record. Parents can sign a release form to provide access to medical records.
• If your child is planning to have surgery as a part of their planned medical care, parents have the option to allow a sample (excess tissue) to be collected for research at the time of surgery.
• No travel required.

Healthcare providers who see patients with neonatal Marfan syndrome

• We are also collecting clinical data retrospectively for patients who are deceased and/or are not actively being followed.

Please contact us at MAC@uth.tmc.edu or 713-500-6715 for more information about this study.

The vEDS Collaborative is dedicated to supporting the Vascular Ehlers-Danlos community in driving patient-centered outcomes research (PCOR) to improve the management of vEDS and increase the quality of life for people impacted by vEDS.

As part of the vEDS Collaborative, the University of Washington is conducting a natural history study to define the contribution of known vEDS gene mutations to vEDS complications and outcomes. The researchers are seeking individuals 18 years of age or older with molecular confirmation of Vascular Ehlers-Danlos Syndrome (i.e., diagnosis through genetic testing results or skin biopsy results) who are willing to share their medical records and radiologic imaging to support a natural history study where the course of vEDS can be followed.

The hope is that this work will lead to treatment guidelines based on the underlying gene mutation and the discovery and/or creation of novel medical practices, diagnostic tools, protective therapies and medicines for the future that will prevent and/or cure the complications of vEDS.

If you are interested in taking part in the study or would like more information, please contact the study team at (206) 353-3076 or vedscoll@ohsu.edu.

Researchers at the University of Texas Health Science Center at Houston are participating in the Registry on Pregnancy and Cardiac Disease (ROPAC), a worldwide project of the European Society of Cardiology. They are currently enrolling any women who became pregnant any time after December 2017 and who have, or have had, one of the following heart or blood vessel problems:

• Aortic aneurysm
• Aortic dissection
• Heart valve replacement surgery
• Marfan syndrome, Loeys-Dietz syndrome, or another condition that can cause aortic aneurysms or dissections

If you meet these criteria, you may be eligible for the study.  Enrollment takes only minutes and your contribution will provide lasting benefits to other women who have potentially fatal conditions. If you would like additional information or if you would like to enroll, please call the ROPAC study team at 713-500-6704.

Doctors and scientists have only identified about 20% of the genes that cause aortic aneurysms and acute aortic dissections that are inherited in families. Studies are now looking at the role of genetics in patients who have had an aortic dissection but do not have a family history.

Dianna Milewicz, MD, PhD, Director of the John Ritter Research Program in Aortic and Vascular Diseases at the University of Texas Health Science Center in Houston, is an internationally recognized expert in the genetics of aortic and vascular diseases. She is working with a team of clinicians, scientists, and genetic counselors in a number of ongoing research studies. These research studies aim to learn more about the genes that predispose people to thoracic aortic aneurysms and acute aortic dissections. Further identification of the genes that cause people to have these conditions will increase our ability to identify who is at risk and provide information on how to better diagnose and manage aortic and vascular diseases.

If you have been diagnosed with a thoracic aortic aneurysm or dissection, or have a family member with this condition, and no one in your family has been diagnosed with Marfan syndrome, Loeys-Dietz syndrome, or Ehlers-Danlos syndrome, please consider taking part in this research study.

To learn more about the research and how to enroll, please contact the genetic counselor involved in the study at JRRP.research@uth.tmc.edu. The genetic counselor will explain the study to you, review your family history, and help you enroll in the research study for which you qualify.

The Genomic Services Research Program (GSRP) is a study of people with “secondary results” from genetic testing. Secondary results are unexpected. They are not related to the reason the person had the genetic test but are shared because they may be very important to the person’s health. Most secondary results have to do with high risks for health problems that can be treated or prevented. Many of these results are related to cancer risk and heart conditions. If you think you have received a secondary result, you may be eligible to join this study.

The purpose of this study is to learn about how people react to their secondary result and the actions they take after learning this information. If you or a member of your family have been given a secondary result, please consider partnering with us on this research. Together we hope to understand the health impacts of secondary results on you and your family and discover ways to better support people like you.

What is involved in for people who join?

If you join the study, the first phase is a survey and phone interview. We will ask you about any changes you made to your healthcare based on the result. We will also ask if there were recommendations you did not follow and why. Finally, we will ask questions about sharing the result with your family members. Following the interview you may be invited to the second phase of the study, which could include extra testing for you and/or your family members at the NIH or in your area. Participating in this study and having testing done at the NIH is free. If we ask you to come to the NIH, and you live in the United States, we will pay for your travel and a hotel.

Eligibility:
• Must speak English or Spanish
• Must have received a genetic testing result related to cancer risk or heart disease even though they were not having genetic testing to get information about this condition.

For more information, please visit: https://www.genome.gov/Current-NHGRI-Clinical-Studies/Genomic-Services-Research-Program